AMEH
FY2026 EPS Estimate
$2.47
FY2026E EPS$2.47

Analyst Sentiment

Wall St. Consensus
Buy
3 analysts·Low coverage
67
Score
2 Buy (67%)1 Hold (33%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
267%
Hold
133%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$40.00
-2.0%
Consensus
$48.50
+18.8%
Bull
$57.00
+39.6%
12-Month Target Range3 analysts
$40.00$48.50$57.00
Current $40.82Consensus
Current Price
$40.82
Upside to Consensus
$7.68

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026E
Revenue Avg$2.33B
Low$2.33B
High$2.33B
EBITDA Avg$310M
Low$310M
High$310M
EBIT Avg$236M
Low$236M
High$236M
Net Income Avg$122M
Low$122M
High$122M
EPS Avg$2.47
Low$2.47
High$2.47
Analysts (Rev / EPS)1 / 1

Earnings Surprises

Recent Analyst Actions

Dec 19, 2022Lake Street
Lake Street Initiates Coverage On Apollo Medical Hlgs with Buy Rating, Announces Price Target of $40
Target:$40.00
+35.8%from $29.45
Aug 8, 2022Barclays
Barclays Maintains Equal-Weight on Apollo Medical Hlgs, Raises Price Target to $57
Target:$57.00
+5.1%from $54.21
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.